abstract |
A compound of formula (I) wherein X, Y, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined herein Or a pharmaceutically acceptable salt thereof. Further disclosed are methods of using the compounds to treat diseases associated with P2X 3 and / or P2X 2/3 receptor antagonists, as well as methods of making the compounds. |